US Stock MarketDetailed Quotes

TVTX Travere Therapeutic

Watchlist
  • 5.260
  • -0.130-2.41%
Close Apr 26 16:00 ET
400.33MMarket Cap-3506P/E (TTM)

Travere Therapeutic Key Stats

Travere Therapeutic Earnings Date

Currency: USD

Period

Q4 FY2023 Earnings

Feb 15, 2024

Revenue(YoY)

45.06M

+53.58%
EPS(YoY)

-1.18

-14.56%

Buy

Apr 28, 2024

Travere Therapeutic Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 13 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q2-- / 52.018M--
--2024/Q1-- / 43.616M--
Feb 15, 20242023/Q445.059M / 41.816M--
Nov 7, 20232023/Q337.095M / 56.450M--
Aug 3, 20232023/Q259.697M / 53.604M--
May 4, 20232023/Q156.993M / 50.608M--
Feb 23, 20232022/Q455.868M / 53.020M--
Oct 27, 20222022/Q353.496M / 54.118M--
Aug 4, 20222022/Q254.167M / 49.580M--
May 5, 20222022/Q148.487M / 51.920M--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q2-- / 52.018M--
--2024/Q1-- / 43.616M--
Feb 15, 20242023/Q445.059M / 41.816M--
Nov 7, 20232023/Q337.095M / 56.450M--
Aug 3, 20232023/Q259.697M / 53.604M--
May 4, 20232023/Q156.993M / 50.608M--
Feb 23, 20232022/Q455.868M / 53.020M--
Oct 27, 20222022/Q353.496M / 54.118M--
Aug 4, 20222022/Q254.167M / 49.580M--
May 5, 20222022/Q148.487M / 51.920M--

Unlock Free Earnings Estimates

Travere Therapeutic Earnings Reports

Read more

Analysis

Analyst Rating

Updated: Apr 28, 2024

Buy

  • Buy

    72.73%
  • Hold

    27.27%
  • Sell

    0.00%

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg